MENLO PARK, Calif., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, September 30, 2015 at 8 a.m. Pacific time to discuss its results for the first quarter fiscal 2016. Financial results will be reported for the 2016 fiscal first quarter ended August 30, 2015 after market close on September 29, 2015.
Landec's Chairman and CEO, Gary T. Steele, will host the Conference Call with Gregory S. Skinner, Vice President and CFO and Molly Hemmeter, COO and CEO Elect. A question and answer period will follow the presentation.
Date: Wednesday, September 30, 2015
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: 866-814-1914
U.S. and International Toll Number: 703-639-1358
Conference ID: 1662667
Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through October 30, 2015.
A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, October 7, 2015.
Toll free replay dial in: 888-266-2081
International replay: 703-925-2533
Replay passcode: 1662667
About Landec Corporation
Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at www.landec.com.